Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 720 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find... May 21, 2020 Choosing to act on cancer: Our Manifesto for Cancer Research and... April 20, 2023 Opinion: ‘Beating cancer means beating it for everyone’ January 29, 2021 FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell... July 11, 2025 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Acalabrutinib Improving Care for Underserved People With Cancer and Evaluating Delays in... EMA Recommends Extending Indications for Pembrolizumab to Include Adjuvant Treatment in... 5 Tips to Move Beyond the Bedside
